U.K. pharmaceutical giant AstraZeneca is considering a deal to merge with its U.S. rival Bristol Myers Squibb.

The Nasdaq-100 just suffered its steepest monthly decline in more than a year. The tech-driven benchmark fell more than 7% in July, the most since a loss of 7.7% in March 2025. Attacks in and around ...

Oil price volatility caused by U.S.-Iran war created big market winners, but for buy-and-hold investors, there are better ...

Flights are getting more expensive this year and airline executives say travelers shouldn't expect prices to come down ...

Brand New Day" snared $355 million in estimated domestic box office on its opening weekend, the second-highest debut of all ...

In his Sunday column, Jim Cramer explains why Amazon is his favorite hyperscaler after second-quarter earnings season.

Some states — including Connecticut, Minnesota and Rhode Island — have expanded their own student loan programs amid new ...

Finance Minister Satsuki Katayama is likely to stress the two countries' determination to combat what they see as excessive ...

In a new interview with CNBC, a Goldman exec breaks down what's driving stocks, where markets are headed, and how the bank’s ...

The U.S. president said Iran and its regional neighbors asked the U.S. to hold off any attacks after 'the perimeters of a deal has been agreed to'.

Tracking top analysts can help investors shortlist attractive dividend stocks, as these experts provide useful insights.

While the leak of key exam papers was the trigger for the recent student protest in India, rising unemployment is the real fuel angering Gen Z in the country.